Target Identification/ Validation News for September 2016

Scientists discover how “super enzyme” speeds up DNA repair

A ‘super enzyme’ known as PARP3 can help to accelerate the repair of DNA – according to scientists from the University of Sussex.
06 September, 2016

MRC Technology, AstraZeneca, Asthma UK and British Lung Foundation enter into collaboration to explore novel treatments for respiratory diseases

Collaboration to look into link between epigenetics and respiratory disease.London, UK, 1 September 2016: A charity-industry collaboration has launched an initiative to find new epigenetic drug treatments to improve the lives of millions of people affected by respiratory diseases every year.
02 September, 2016

Target Identification/ Validation News for September 2016

Target Identification/ Validation News Archive

Scientists discover how “super enzyme” speeds up DNA repair Scientists discover how “super enzyme” speeds up DNA repair

MRC Technology, AstraZeneca, Asthma UK and British Lung Foundation enter into collaboration to explore novel treatments for respiratory diseases MRC Technology, AstraZeneca, Asthma UK and British Lung Foundation enter into collaboration to explore novel treatments for respiratory diseases

Scientists discover how “super enzyme” speeds up DNA repair

MRC Technology, AstraZeneca, Asthma UK and British Lung Foundation enter into collaboration to explore novel treatments for respiratory diseases